Cargando…

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study

BACKGROUND: Many patients with advanced cancer depend upon health care providers for symptom assessment. The extent of agreement between patient and provider symptom assessments and the association of agreement with demographic- and disease-related factors was examined. METHODS: This cross-sectional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laugsand, Eivor A, Sprangers, Mirjam AG, Bjordal, Kristin, Skorpen, Frank, Kaasa, Stein, Klepstad, Pål
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949821/ https://www.ncbi.nlm.nih.gov/pubmed/20858248 http://dx.doi.org/10.1186/1477-7525-8-104

Ejemplares similares

Inadequate symptom control in advanced cancer patients across Europe
por: Laugsand, Eivor A., et al.
Publicado: (2010)

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
por: Kurita, Geana Paula, et al.
Publicado: (2016)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
por: Andersen, Sonja, et al.
Publicado: (2013)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
por: Andreassen, Trine Naalsund, et al.
Publicado: (2011)

Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
por: Barratt, Daniel T., et al.
Publicado: (2015)

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory
por: Stenseth, Guri, et al.
Publicado: (2007)

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
por: Løhre, Erik Torbjørn, et al.
Publicado: (2018)

Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study
por: Brenne, Siv S., et al.
Publicado: (2023)

Management of a life-threatening intercostal artery bleeding, difficult to visualize in open surgery: a case report
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Psychological distress in head and neck cancer patients 7-11 years after curative treatment.
por: Bjordal, K., et al.
Publicado: (1995)

Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study
por: Verkissen, Mariëtte N., et al.
Publicado: (2019)

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
por: Colombo, Francesca, et al.
Publicado: (2020)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2018)

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
por: Paulsen, Ørnulf, et al.
Publicado: (2017)

Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
por: Olesen, Anne Estrup, et al.
Publicado: (2018)

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
por: Klepstad, Pål, et al.
Publicado: (2004)

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015)

An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer
por: Dolan, Ross D., et al.
Publicado: (2019)

Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
por: Bye, Asta, et al.
Publicado: (2022)

No guts, no glory: underestimating the benefits of providing children with mechanistic details
por: Chuey, Aaron, et al.
Publicado: (2021)

Risk factors for right colon, left colon and rectal cancers differ between men and women: the population‐based HUNT study in Norway
por: Brenne, Siv S., et al.
Publicado: (2022)

Fatigue – an underestimated symptom in psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2017)

Is Ataxia an Underestimated Symptom of Huntington's Disease?
por: Franklin, Gustavo L., et al.
Publicado: (2020)

Reflections on changeability versus stability of health-related quality of life: distinguishing between its environmental and genetic components
por: Sprangers, Mirjam AG, et al.
Publicado: (2008)

The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2020)

Diarrhea: An underestimated symptom in Coronavirus disease 2019
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
por: Aukland, Eirik Aasen, et al.
Publicado: (2022)

Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
por: Boland, Jason W, et al.
Publicado: (2018)

Herpes simplex and intensive care medicine: an underestimated problem?
por: Camps, K, et al.
Publicado: (1999)

Individuals Underestimate Moderate and Vigorous Intensity Physical Activity
por: Canning, Karissa L., et al.
Publicado: (2014)

Hyperchloremia in Intensive Care Unit Mortality: An Underestimated Fact
por: Shad, Zahid Siddique, et al.
Publicado: (2019)

Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden
por: Zonneveld, Lyonne NL, et al.
Publicado: (2013)

The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial
por: Prinsen, Cecilia AC, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_93r6jkbudk8o6gaipg88lhbhdi